Jay Rahematpura
About Jay Rahematpura
Jay Rahematpura is the Executive Director of Alliance Management, Research and Early Development at Bristol-Myers Squibb in Summit, NJ, with extensive experience in global supply chain planning and strategic sourcing.
Current Position at Bristol-Myers Squibb
Jay Rahematpura currently serves as the Executive Director of Alliance Management, Research, and Early Development at Bristol-Myers Squibb. Based in Summit, NJ, his role involves overseeing strategic partnerships and alliances crucial to the research and early development stages of drug discovery.
Previous Experience at Celgene
Jay Rahematpura has an extensive background in supply chain and demand planning through various significant roles at Celgene. From 2017 to 2020, he was the Senior Director of Technical Commercialization in Summit, NJ. Prior to that, he managed global demand planning as a Senior Director from 2014 to 2017 in Geneva, Switzerland. He also held the position of Director of Global Supply Chain Planning from 2012 to 2014.
Role at Deloitte Consulting
From 2010 to 2012, Jay Rahematpura worked as a Manager at Deloitte Consulting, where he gained valuable consulting experience. His role likely involved working on various projects related to supply chain management and strategic sourcing, given his extensive expertise in these areas.
Experience at Merck
Jay Rahematpura has a strong background in contract manufacturing strategy and alliances from his tenure at Merck. He served as the Director of Contract Manufacturing Strategy and Alliances twice, once from 2007 to 2009 and again from 2009 to 2010. During these periods, he focused on developing and managing strategic manufacturing contracts and alliances.
Educational Background
Jay Rahematpura holds a Ph.D. in Chemistry from the University of Düsseldorf, which he earned between 1988 and 1999. Additionally, he received an MBA in General Management from Purdue University's Krannert School of Management in 2004. He also attended the Investment Banking Institute for Financial Modeling and Valuation Training in 2010.